KR840003415A - 경구용 당뇨병 치료제의 제조방법 - Google Patents

경구용 당뇨병 치료제의 제조방법 Download PDF

Info

Publication number
KR840003415A
KR840003415A KR1019830000575A KR830000575A KR840003415A KR 840003415 A KR840003415 A KR 840003415A KR 1019830000575 A KR1019830000575 A KR 1019830000575A KR 830000575 A KR830000575 A KR 830000575A KR 840003415 A KR840003415 A KR 840003415A
Authority
KR
South Korea
Prior art keywords
carrier
polyoxyethylene
stearate
polyoxy
melting point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019830000575A
Other languages
English (en)
Korean (ko)
Inventor
안토니 갠리 존
Original Assignee
케네스 프레드릭 킨치
훽스트 유케이 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 케네스 프레드릭 킨치, 훽스트 유케이 리미티드 filed Critical 케네스 프레드릭 킨치
Publication of KR840003415A publication Critical patent/KR840003415A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019830000575A 1982-02-15 1983-02-12 경구용 당뇨병 치료제의 제조방법 Withdrawn KR840003415A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB08204363A GB2118040A (en) 1982-02-15 1982-02-15 Oral anti-diabetic preparation
GB4363 1982-02-15

Publications (1)

Publication Number Publication Date
KR840003415A true KR840003415A (ko) 1984-09-08

Family

ID=10528336

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830000575A Withdrawn KR840003415A (ko) 1982-02-15 1983-02-12 경구용 당뇨병 치료제의 제조방법

Country Status (14)

Country Link
EP (1) EP0086468A3 (https=)
JP (1) JPS58152814A (https=)
KR (1) KR840003415A (https=)
AU (1) AU1140983A (https=)
DK (1) DK64183A (https=)
ES (1) ES519771A0 (https=)
FI (1) FI830483A7 (https=)
GB (1) GB2118040A (https=)
GR (1) GR78063B (https=)
IE (1) IE830290L (https=)
IL (1) IL67908A0 (https=)
NO (1) NO830491L (https=)
PT (1) PT76236A (https=)
ZA (1) ZA83986B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3320582A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung
DE3320583A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
DE3325986C2 (de) * 1983-07-19 1985-05-23 Klinge Pharma GmbH, 8000 München Schnell resorbierbare Zubereitung schwer löslicher Wirkstoffe
DK164642C (da) * 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
NL8503539A (nl) * 1986-01-02 1987-07-16 Warner Lambert Co Sucrose-vrije preparaten.
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
GB8701332D0 (en) * 1987-01-21 1987-02-25 Lilly Industries Ltd Capsule filling
DE3743946A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
DE3743947A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur gesteuerten abgabe von nicotin, verfahren zu ihrer herstellung sowie ihre verwendung
DE3743945A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von stoffen, verfahren zu ihrer herstellung sowie ihre verwendung
US4936074A (en) * 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament
DE3919982A1 (de) * 1989-06-19 1990-12-20 Liedtke Pharmed Gmbh Orale lipidarzneiform
US5258185A (en) * 1989-08-23 1993-11-02 Bauer Kurt H Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use
DE3927882A1 (de) * 1989-08-23 1991-02-28 Bauer Kurt Heinz Hochwirksame, schnell resorbierbare zubereitungsformen von glibenclamid, verfahren zu ihrer herstellung und ihre verwendung
CH683594A5 (de) * 1991-01-24 1994-04-15 Flachsmann Ag Emil Verfahren zur Herstellung eines Pflanzenextrakt enthaltenden Masse, welche insbesondere für die Einkapselung in ein festes Umhüllungsmaterial geeignet ist.
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
DE4336159A1 (de) * 1993-10-22 1995-04-27 Kurt Heinz Prof Dr Bauer Hochwirksame, den Wirkstoff schnell oder kontrolliert freisetzende Zubereitungsformen von Sulfonylharnstoffen und Verfahren zu deren Herstellung
ATE201139T1 (de) * 1997-06-13 2001-06-15 Novo Nordisk As Neue dosierung für diabetes type 2
US6387400B1 (en) 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
US8231896B2 (en) 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1591573A (https=) * 1968-05-10 1970-05-04
BE757586A (fr) * 1969-10-17 1971-04-15 Hoechst Ag Forme pharmaceutique a liberation programmee de la substance active
NL7314765A (https=) * 1972-10-31 1974-05-02
DE2614864C3 (de) * 1976-04-06 1979-11-29 Schwabe, Willmar, Dr., 7500 Karlsruhe Verfahren zur Herstellung Digoxin enthaltender Arzneipräparate in Weichgelatinekapseln zur oralen Verabfolgung
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form

Also Published As

Publication number Publication date
FI830483L (fi) 1983-08-16
IE830290L (en) 1983-08-15
ES8406879A1 (es) 1984-09-01
ZA83986B (en) 1983-10-26
PT76236A (en) 1983-03-01
ES519771A0 (es) 1984-09-01
FI830483A0 (fi) 1983-02-11
DK64183A (da) 1983-08-16
IL67908A0 (en) 1983-06-15
EP0086468A3 (en) 1983-09-28
GR78063B (https=) 1984-09-26
JPS58152814A (ja) 1983-09-10
EP0086468A2 (en) 1983-08-24
GB2118040A (en) 1983-10-26
AU1140983A (en) 1983-08-25
FI830483A7 (fi) 1983-08-16
DK64183D0 (da) 1983-02-14
NO830491L (no) 1983-08-16

Similar Documents

Publication Publication Date Title
KR840003415A (ko) 경구용 당뇨병 치료제의 제조방법
KR890007739A (ko) 안정화된 의약물질, 이의 제조방법, 및 안정한 의약제제
IS1564B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
CA2168732A1 (en) Gelatin Capsules Containing a Highly Concentrated Acetaminophen Solution
DE3678661D1 (de) Arzneimittel mit langsamer wirkstofffreisetzung.
KR840000228A (ko) 조제성 혼합물에 있어서 건성분말의 제조방법
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
KR870003772A (ko) 2-(2-플루오로-4-비페닐릴)프로피온산을 함유하는 약제학적 조성물의 제조방법
KR830005854A (ko) 알카리성 진통제 캡슐의 제조방법
ATE67406T1 (de) Nicorandil enthaltende zubereitung zum einspritzen.
ES2059312T3 (es) Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion.
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
JPS57109721A (en) Carcinostatic agent
JPS5522631A (en) Readily absorbable nifedipine preparation
FR2447720A1 (fr) Procede de stabilisation thermique et d'amelioration de la stabilite dimensionnelle des capsules de gelatine molle contenant le medicament dans l'enveloppe
ATE175870T1 (de) Pharmazeutische zubereitung zur rektalen verabreichung von pharmakologisch wirksamen verbindungen
US5707651A (en) Soft capsules containing dinreburnamenine compounds
RU2108787C1 (ru) Фармацевтические мягкие капсулы, содержащие лизинхлониксинат, способ их получения
KR870003777A (ko) 조절된 방출성의 약학적 제제
JPS52130905A (en) Medicinal composition
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
GB922442A (en) Steroids
JPS6351332A (ja) 安定な医薬品組成物
ES531969A1 (es) Procedimiento para preparar un medicamento que contiene 1- (4-(2-(5-cloro-2-metoxi-benzamido)-etil)-fenilsulfonil)-3-ciclohexil-urea en forma de una capsula de gelatina blanda

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19830212

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid